Recombinant HIV-1 Antigens

Human Immunodeficiency Virus type 1 (HIV-1) is the predominant cause of HIV infection worldwide and remains a major global health challenge. Our broad portfolio of recombinant HIV-1 antigens supports serological research, assay development, and diagnostic applications.

We offer recombinant antigens covering key structural, envelope, and enzymatic HIV-1 proteins, including Group M p17, p21, p31, p51, gp41, gp120, gp160, and an O Env Mosaic antigen. Produced under controlled conditions, these antigens provide high purity, excellent consistency, and dependable performance across ELISA and other immunoassay platforms.